肺表面活性剂 - 生物仿真膜化协体注射用于急性呼吸困扰综合征治疗
Wei Chen1, Qi Xie1, Zhanhao Zhou2
1Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.
Acta pharmaceutica Sinica. B
|November 28, 2025
概括
这项研究引入了一种新的生物仿真膜化协酸 (DSP@PS-Coac) 用于治疗急性呼吸困扰综合征 (ARDS). 这种创新疗法可以增强药物输送到肺部,减少炎症,并提供一个有前途的新治疗方案.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 急性呼吸困扰综合征 (ARDS) 是一种危急的疾病,导致严重的呼吸衰竭,发病率和死亡率.
- 基于肺表面活性剂 (PS) 的疗法显示出对ARDS治疗作为辅助策略的希望.
- 协体 (Coac) 具有独特的特性,如可变形性和生物医学应用的分子丰富性.
研究的目的:
- 开发一种新型的肺表面活性剂-生物仿真膜化协酸盐 (DSP@PS-Coac),用于增强急性呼吸困扰综合征 (ARDS) 治疗.
- 在ARDS小鼠模型中评估DSP@PS-Coac的肺向,透效率和治疗疗效.
主要方法:
- 从聚亚胺化物 (PAH) 和腺三酸盐 (ATP) 制造协酸盐 (Coac),用于甲酸盐 (DSP) 丰富.
- 通过结合PS-生物模拟脂质体 (PS-lipo) 来构建PS-生物模拟膜化共体 (DSP@PS-Coac),以防止融合并增加生物功能.
- 在静脉注射后评估DSP@PS-Coac肺准和透效率.
- 在ARDS小鼠模型中评估抗炎作用,包括炎症细胞招募和巨细胞调节.
主要成果:
- DSP@PS-Coac表现出优异的软滴状性质和高缩能力为甲酸 (DSP).
- 这种新型配方在静脉注射后显示出显著的肺向和透效率.
- 在ARDS小鼠模型中,DSP@PS-Coac有效地减少了炎症性中性粒细胞的招募,并调节了巨细胞向抗炎症表型.
- PS-Coac和DSP的联合治疗显示出协同作用的抗炎作用.
结论:
- DSP@PS-Coac代表了对ARDS治疗的有前途的交付系统,利用同和生物模拟脂质体的好处.
- 该配方有效地向肺部,并提供甲酸,减少炎症.
- 这种方法为治疗急性呼吸困扰综合征提供了潜在的新疗法策略.
相关概念视频
01:29Acute Respiratory Failure-V
407
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
407
01:05Breathing
64.1K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.1K
01:23Acute Respiratory Failure-IV
486
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
486
01:21Acute Respiratory Failure-II
974
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
974
01:30Acute Respiratory Failure-III
714
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
714
01:21Acute Respiratory Failure-I
779
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
779